Moreover, CD155 is not only expressed by tumour cells but also by myeloid suppressive cells in TME, subsequently leading to low expression of DNAM-1 on both NK and T cells, resulting in their impaired cytotoxic activity [112]. The gene discussed is PVR; the disease is neoplasm.